| dbo:description
|
- شركة سويسرية (ar)
- bedrijf in Zwitserland (nl)
- Compañía Farmacéutica (es)
- Schweizer Pharmaunternehmen (de)
- Swiss biopharmaceutical company (en)
- szwajcarska firma biofarmaceutyczna (pl)
- スイスの製薬企業 (ja)
|
| dbo:foundingYear
| |
| dbo:keyPerson
| |
| dbo:numberOfEmployees
|
- 2624 (xsd:nonNegativeInteger)
|
| dbo:operatingIncome
| |
| dbo:parentCompany
| |
| dbo:product
| |
| dbo:revenue
| |
| dbo:thumbnail
| |
| dbo:type
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageWikiLink
| |
| dbp:areaServed
|
- Research and Development of medicines for unmet medical need (en)
|
| dbp:bot
| |
| dbp:date
| |
| dbp:defunct
| |
| dbp:fate
|
- acquired by Actelion (en)
|
| dbp:fixAttempted
| |
| dbp:foundation
| |
| dbp:founders
|
- Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann (en)
|
| dbp:homepage
| |
| dbp:industry
| |
| dbp:keyPeople
|
- Jean-Paul Clozel (en)
- Donald J. Santel, CEO & Director (en)
|
| dbp:location
| |
| dbp:locationCity
| |
| dbp:locationCountry
| |
| dbp:logo
|
- Cotherix logo.png (en)
- Logo Actelion.svg (en)
|
| dbp:name
|
- Actelion Pharmaceuticals Ltd. (en)
- CoTherix, Inc. (en)
|
| dbp:numEmployees
|
- 100 (xsd:integer)
- 2624 (xsd:integer)
|
| dbp:operatingIncome
| |
| dbp:parent
| |
| dbp:products
|
- dbr:Iloprost
- Tracleer, Ventavis, Zavesca, Veletri, Opsumit (en)
|
| dbp:revenue
|
- 6.3E7 (dbd:usDollar)
- 2.412E9 (dbd:swissFranc)
|
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dct:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:label
|
- Actelion (en)
- Actelion (de)
- Actelion (es)
- Actelion (fr)
- アクテリオン (ja)
- Actelion (pt)
|
| owl:sameAs
| |
| skos:closeMatch
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Actelion Pharmaceuticals Ltd. (en)
|
| is dbo:knownFor
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
